Skip to main content

Table 3 CYP3A4 and CYP3A5 genotypes in colorectal cancer patients according tumor site.

From: Genetic variability in CYP3A4 and CYP3A5in primary liver, gastric and colorectal cancer patients

CYP3A4

CYP3A5

NON-SIGMOID

N (FREQUENCY; 95% C.I.)

SIGMOID

N (FREQUENCY; 95% C.I.)

RECTUM

N (FREQUENCY; 95% C.I.)

*1A/*1A

*3/*3

33 (73.3; 60.4–86.3)

40 (78.4; 67.1–89.7)

48 (87.3; 78.5–96.1)

*1A/*1A

*1/*3

6 (13.3; 3.4–23.3)

6 (11.8; 2.9–20.6)

6 (10.9; 2.7–19.1)

*1A/*1B

*3/*3

4 (8.8; 0.6–17.2)*

1 (2.0; 0–5.8)

0

*1A/*1B

*1/*3

2 (4.4; 0–10.5)

3 (5.9; 0–12.3)

1 (1.8; 0–5.3)

*1B/*1B

*1/*3

0

1 (2.0; 0–5.8)

0

  1. *p < 0.0015 compared to healthy subjects